ABIVAX SA-ADR (ABVX) Stock Analyst Ratings
NASDAQ:ABVX - Nasdaq - US00370M1036 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ABVX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.49. This target is 298.13% above the current price.
ABVX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ABVX.
In the previous month the buy percentage consensus was at a similar level.
ABVX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-04 | JMP Securities | Initiate | Market Outperform |
| 2024-07-29 | Laidlaw & Co. | Initiate | Buy |
| 2024-05-20 | BTIG | Initiate | Buy |
| 2024-04-29 | Guggenheim | Initiate | Buy |
| 2024-04-29 | Piper Sandler | Initiate | Overweight |
| 2024-04-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-14 | Leerink Partners | Initiate | Outperform |
| 2023-11-14 | Morgan Stanley | Initiate | Equal-Weight |